학술논문 – 법학도서관

학술논문

replay검색결과 돌아가기

search검색화면

Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial

Document Type

Article

Author

Rojas, Jhon ; de Lazzari, Elisa ; Negredo, Eugenia; Domingo, Pere; Tiraboschi, Juan; Ribera, Esteve; Abdulghani, Nadia; Puig, Jordi; Mateo, Maria G; Podzamczer, Daniel; Gutierrez, Maria M; Paredes, Roger; Clotet, Bonaventura; Gatell, Jose M; Blanco, Jose L ; Martínez, Esteban

Source

In The Lancet HIV August 2021 8(8):e463-e473

Subject

Primary Research
Articles

Language

ISSN

2352-3018

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일